Rxo annual depreciation and amortization
2020
2021
2022
2023
2024
2025
Rxo Depreciation & Amortization Growth & History (RXO)
Rxo's depreciation and amortization was $116.0M for fiscal 2025.
View full Rxo company overviewRxo annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $116.0M | $29.0M | +33.33% |
| 2024 | 2024-12-31 | $87.0M | $20.0M | +29.85% |
| 2023 | 2023-12-31 | $67.0M | −$19.0M | −22.09% |
| 2022 | 2022-12-31 | $86.0M | $5.0M | +6.17% |
| 2021 | 2021-12-31 | $81.0M | $5.0M | +6.58% |
| 2020 | 2020-12-31 | $76.0M | — | — |
Rxo quarterly depreciation and amortization
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $26.0M | −$4.0M | −13.33% |
| Q1 2026 | 2026-03-31 | $26.0M | −$6.0M | −18.75% |
| Q4 2025 | 2025-12-31 | $28.0M | — | — |
| Q3 2025 | 2025-09-30 | $26.0M | $5.0M | +23.81% |
| Q2 2025 | 2025-06-30 | $30.0M | $13.0M | +76.47% |
| Q1 2025 | 2025-03-31 | $32.0M | $16.0M | +100.00% |
| Q3 2024 | 2024-09-30 | $21.0M | $5.0M | +31.25% |
| Q2 2024 | 2024-06-30 | $17.0M | −$1.0M | −5.56% |
| Q1 2024 | 2024-03-31 | $16.0M | −$2.0M | −11.11% |
| Q3 2023 | 2023-09-30 | $16.0M | −$7.0M | −30.43% |
| Q2 2023 | 2023-06-30 | $18.0M | −$3.0M | −14.29% |
| Q1 2023 | 2023-03-31 | $18.0M | −$3.0M | −14.29% |
| Q3 2022 | 2022-09-30 | $23.0M | $1.0M | +4.55% |
| Q2 2022 | 2022-06-30 | $21.0M | — | — |
| Q1 2022 | 2022-03-31 | $21.0M | — | — |
| Q3 2021 | 2021-09-30 | $22.0M | — | — |
Rxo depreciation and amortization trends
Over the last five fiscal years, Rxo's depreciation and amortization increased from $76.0M to $116.0M, a change of $40.0M. The latest reported quarter, Q2 2026, shows $26.0M.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Rxo source filings ↗